We serve Chemical Name:ethyl 2-(3,4-difluorophenyl)sulfonylacetate CAS:1094476-62-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 2-(3,4-difluorophenyl)sulfonylacetate
CAS.NO:1094476-62-6
Synonyms:2-[(3,4-difluorophenyl)sulfonyl]acetic acid ethyl ester
Molecular Formula:C10H10F2O4S
Molecular Weight:264.24600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.371
Index of Refraction:
PSA:68.82000
Exact Mass:264.02700
LogP:2.38240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-[(3,4-difluorophenyl)sulfonyl]acetic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[(3,4-difluorophenyl)sulfonyl]acetic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-[(3,4-difluorophenyl)sulfonyl]acetic acid ethyl ester Use and application,2-[(3,4-difluorophenyl)sulfonyl]acetic acid ethyl ester technical grade,usp/ep/jp grade.
Related News: In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. 1-[2-deoxy-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-ribofuranosyl]thymine manufacturers In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers. phenyl 2-bromopropanoate suppliers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. 2-(4-Bromophenyl)-6-(4-methylphenyl)-4-phenylpyridine vendor & factory.
